Featured Research

from universities, journals, and other organizations

Test Predicts Risk Of Liver Scarring After Transplant, Study Shows

Date:
October 6, 2005
Source:
University of North Carolina School of Medicine
Summary:
A study from the University of North Carolina at Chapel Hill School of Medicine may have found a way to identify liver transplant patients with hepatitis C who are at greatest risk for advanced cirrhosis, thereby allowing doctors to decide who should receive treatment that could save the transplanted organ.

CHAPEL HILL -- An estimated 20 percent of people with chronichepatitis C who receive a liver transplant will develop advancedcirrhosis, scarring of the new organ severe enough to impair itsability to function normally within five years of transplantation.

A new study from the University of North Carolina at Chapel Hill Schoolof Medicine may have found a way to identify those at greatest risk,thereby allowing doctors to decide who should receive treatment thatcould save the transplanted organ. The new findings appear in theOctober issue of the journal Liver Transplantation.

The research found a laboratory test that shows activation of a certaintype of liver cell -- hepatic stellate cells -- to be useful indetermining high risk for developing cirrhosis.

"Right now, there are no reliable tests for identifying the groupthat's at high risk," said lead author Dr. Mark W. Russo, assistantprofessor of medicine in the Division of Gastroenterology andHepatology at UNC. "The reason you want to identify that group isbecause there are some people who will not go on to develop cirrhosisfrom hepatitis C after liver transplant and the therapy has a lot ofside effects and is also very expensive."

This antiviral drug therapy is effective in only 10 percent to 30percent of liver transplant recipients, the research team reported.Moreover, side effects, including anemia, cause roughly the samepercentage of patients to stop the treatment.

Russo and collaborators from UNC and the University of Florida focusedon hepatic stellate cells (HSCs), which normally store vitamin A in theliver. But they produce collagen and other proteins that can lead tofibrosis, or scarring, in patients infected with hepatitis C virus.

The research team hypothesized that a known valid biomarker of HSCactivation -- alpha smooth muscle actin (alpha-SMA) -- could predictwhich patients would later develop fibrosis.

The study involved 46 patients with hepatitis C virus who receivedliver transplants between 1997 and 2001. The patients were divided intotwo groups: those who developed advanced fibrosis within two years ofliver transplant and those who developed mild or no fibrosis in thesame period.

Liver tissue samples from four months, one year and two yearspost-transplant were scored in the laboratory for alpha-SMA. Theresults showed HSC activation to be significantly higher in thefour-month biopsies for those who developed advanced fibrosis withintwo years."These results are exciting because they suggest for the first timethat this biomarker could help us identify liver transplant recipientswith hepatitis C who are at high risk for progressing to advancedfibrosis. But it would be important to confirm this in a largerindependent, prospective study," Russo said.

###

UNC co-authors along with Russo include Dr. Michael Fried and Dr.Roshan Shrestha, professors of medicine within the Division ofGastroenterology and Hepatology; and Robert Schoonhoven, laboratoryresearch specialist in the UNC School of Public Health's department ofenvironmental sciences and engineering. Co-authors from the Universityof Florida include Dr. Roberto Firpi, clinical assistant professor ofmedicine, and Dr. David Nelson, assistant professor of medicine.

Support for the research came from the National Institute ofEnvironmental Health Sciences, a component of the National Institutesof Health.



Story Source:

The above story is based on materials provided by University of North Carolina School of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

University of North Carolina School of Medicine. "Test Predicts Risk Of Liver Scarring After Transplant, Study Shows." ScienceDaily. ScienceDaily, 6 October 2005. <www.sciencedaily.com/releases/2005/10/051006082752.htm>.
University of North Carolina School of Medicine. (2005, October 6). Test Predicts Risk Of Liver Scarring After Transplant, Study Shows. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2005/10/051006082752.htm
University of North Carolina School of Medicine. "Test Predicts Risk Of Liver Scarring After Transplant, Study Shows." ScienceDaily. www.sciencedaily.com/releases/2005/10/051006082752.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins